Tat-heat shock protein 10 could rejuvenate aging brains

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 22, entitled, “Tat-heat shock protein 10 ameliorates age-related phenotypes by facilitating neuronal plasticity and reducing age-related genes in the hippocampus.”

Lilly to build manufacturing capacity at risk to prepare for next-gen oral obesity drug

Eli Lilly is stuck in a hard place — it’s got the capital to spend to boost manufacturing capacity. But the complexity of building, buying

February 7, 2024

Masimo lowers outlook, citing constrained hospital budgets

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 revenue: $478.9 million

November 8, 2023

Psyence Biomed Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin to be Evaluated as a Potential Treatment for Alcohol Use Disorder (AUD) and Other Substance Use Disorders (SUDs) | Psychedelic Invest

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM, PBMWW) (“Psyence Biomed” or the “Company”) today announced that the Company has entered into a worldwide,

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.